Safe and effective use of rivaroxaban for treatment of cancer-associated venous thromboembolic disease: a prospective cohort study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-742X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Safe and effective use of rivaroxaban for treatment of cancer-associated venous thromboembolic disease: a prospective cohort study ; day:30 ; month:9 ; year:2016 ; pages:1-6
Journal of thrombosis and thrombolysis ; (30.9.2016), 1-6
- Urheber
-
Mantha, Simon
- Beteiligte Personen und Organisationen
-
Laube, Eva
Miao, Yimei
Sarasohn, Debra M.
Parameswaran, Rekha
Stefanik, Samantha
Brar, Gagandeep
Samedy, Patrick
Wills, Jonathan
Harnicar, Stephen
Soff, Gerald A.
SpringerLink (Online service)
- DOI
-
10.1007/s11239-016-1429-1
- URN
-
urn:nbn:de:1111-201610319727
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mantha, Simon
- Laube, Eva
- Miao, Yimei
- Sarasohn, Debra M.
- Parameswaran, Rekha
- Stefanik, Samantha
- Brar, Gagandeep
- Samedy, Patrick
- Wills, Jonathan
- Harnicar, Stephen
- Soff, Gerald A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cancer‐associated venous thromboembolism: Treatment and prevention with rivaroxaban
Long-term survival in venous thromboembolic disease: rivaroxaban vs. warfarin – propensity score matching study
Rivaroxaban versus Apixaban for Treatment of Cancer-Associated Venous Thromboembolism in Patients at Lower Risk of Bleeding
Rivaroxaban for the treatment of cerebral venous thrombosis
The Rivaroxaban Program and the Management of Unmet Needs in Thromboembolic Disease
Increased Platelet Adhesiveness in Patients with Venous Thromboembolic Disease
Direct Oral Anticoagulants for Cancer-Associated Venous Thromboembolism
Update on Cancer-Associated Venous Thromboembolism in Children
Treatment Challenges in Venous Thromboembolism: An Appraisal of Rivaroxaban Studies
Comparison of rivaroxaban and low molecular weight heparin in the treatment of cancer-associated venous thromboembolism: a Swedish national population-based register study
Screening for Cancer in Patients with Acute Venous Thromboembolic Disease
Systematic Screening for Venous Thromboembolic Events in COVID-19 Pneumonia
Cancer‐associated venous thromboembolism: Treatment and prevention with rivaroxaban
Long-term survival in venous thromboembolic disease: rivaroxaban vs. warfarin – propensity score matching study
Rivaroxaban versus Apixaban for Treatment of Cancer-Associated Venous Thromboembolism in Patients at Lower Risk of Bleeding
Rivaroxaban for the treatment of cerebral venous thrombosis
The Rivaroxaban Program and the Management of Unmet Needs in Thromboembolic Disease
Increased Platelet Adhesiveness in Patients with Venous Thromboembolic Disease
Direct Oral Anticoagulants for Cancer-Associated Venous Thromboembolism
Update on Cancer-Associated Venous Thromboembolism in Children
Treatment Challenges in Venous Thromboembolism: An Appraisal of Rivaroxaban Studies
Comparison of rivaroxaban and low molecular weight heparin in the treatment of cancer-associated venous thromboembolism: a Swedish national population-based register study
Screening for Cancer in Patients with Acute Venous Thromboembolic Disease
Systematic Screening for Venous Thromboembolic Events in COVID-19 Pneumonia
Cancer‐associated venous thromboembolism: Treatment and prevention with rivaroxaban
Long-term survival in venous thromboembolic disease: rivaroxaban vs. warfarin – propensity score matching study
Rivaroxaban versus Apixaban for Treatment of Cancer-Associated Venous Thromboembolism in Patients at Lower Risk of Bleeding
Rivaroxaban for the treatment of cerebral venous thrombosis
The Rivaroxaban Program and the Management of Unmet Needs in Thromboembolic Disease
Increased Platelet Adhesiveness in Patients with Venous Thromboembolic Disease
Direct Oral Anticoagulants for Cancer-Associated Venous Thromboembolism
Update on Cancer-Associated Venous Thromboembolism in Children
Treatment Challenges in Venous Thromboembolism: An Appraisal of Rivaroxaban Studies
Comparison of rivaroxaban and low molecular weight heparin in the treatment of cancer-associated venous thromboembolism: a Swedish national population-based register study
Screening for Cancer in Patients with Acute Venous Thromboembolic Disease